These proteins are synthesized, processed and can be presented as peptide antigens by major histocompatibility complex (MHC) molecules on the cell surface of tumor cells as well as dendritic cells (DC) that have processed proteins derived from tumor cells. This evidence concerns the gene HLA-C and neoplasm.